Ted Karkus - May 23, 2022 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role: CEO & CHAIRMAN, Director, 10%+ Owner
Signature: /s/ Ted Karkus
Stock symbol: PRPH
Transactions as of: May 23, 2022
Transactions value $: -$1,456,837
Form type: 4
Date filed: 5/25/2022, 05:20 PM
Previous filing: Jun 10, 2021
Next filing: Aug 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRPH	Common Stock, par value $0.005	Options Exercise	$900K	+450K	+19.28%	$2.00	2.78M	May 23, 2022	Direct	F1
transaction	PRPH	Common Stock, par value $0.005	Tax liability	-$2.36M	-278K	-10%	$8.47	2.51M	May 23, 2022	Direct	F1
holding	PRPH	Common Stock, par value $0.005						100K	May 23, 2022	By Son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRPH	Option (right to buy)	Options Exercise	$0	-450K	-100%	$0.00^*	0	May 23, 2022	Common Stock	450K	$2.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 23, 2022, the Reporting Person acquired net 171,743 shares of common stock upon the exercise of stock options to purchase 450,000 shares of common stock, less 278,257 shares of common stock withheld to cover the exercise price and applicable taxes.
F2	The option vested in four equal annual installments beginning April 26, 2018, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of April 27, 2017.